Pages that link to "Q34430779"
Jump to navigation
Jump to search
The following pages link to Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. (Q34430779):
Displaying 29 items.
- Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia (Q28296557) (← links)
- Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. (Q33339733) (← links)
- Incidence of anogenital warts in Germany: a population-based cohort study (Q33779542) (← links)
- Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses (Q33803013) (← links)
- Global Proficiency Study of Human Papillomavirus Genotyping (Q34489632) (← links)
- Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papillomaviruses in neoplasia (Q34559761) (← links)
- Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples (Q34680765) (← links)
- Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples (Q34983076) (← links)
- Human Papillomavirus Types 52 and 58 Are Prevalent in Uterine Cervical Squamous Lesions from Japanese Women (Q35028816) (← links)
- Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review (Q35185950) (← links)
- Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy (Q35605295) (← links)
- Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems (Q35690716) (← links)
- Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study (Q36423668) (← links)
- Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update (Q36584383) (← links)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases (Q36584410) (← links)
- Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination (Q36793117) (← links)
- Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens (Q36813303) (← links)
- Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus (Q37116753) (← links)
- Monitoring HPV vaccination (Q37222471) (← links)
- RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. (Q37256248) (← links)
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older (Q37461977) (← links)
- Monitoring of human papillomavirus vaccination. (Q37808256) (← links)
- Human papillomavirus: science and technologies for the elimination of cervical cancer (Q37901056) (← links)
- Human papilloma virus (HPV) molecular diagnostics. (Q37923517) (← links)
- Role of human papillomaviruses in esophageal squamous cell carcinoma (Q38035068) (← links)
- An in vitro selection scheme for oligonucleotide probes to discriminate between closely related DNA sequences. (Q38302836) (← links)
- Validation of high-risk HPV tests for primary cervical screening (Q43762516) (← links)
- CHAPTER 7 Methods for detection of HPV infection and its clinical utility. (Q54573717) (← links)
- Development of optimal liquid based cytology sample processing methods for HPV testing: Minimising the ‘inadequate’ test result (Q83372722) (← links)